New challenges for pharmacogenomics

Ron H.N. van Schaik

doi:10.1515/dmdi-2013-0060

Home Medicine New challenges for pharmacogenomics

Article

Licensed

Unlicensed Requires Authentication

New challenges for pharmacogenomics

Ron H.N. van Schaik

Published/Copyright: November 23, 2013

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

From the journal Drug Metabolism and Drug Interactions Volume 28 Issue 4

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

van Schaik, Ron H.N.. "New challenges for pharmacogenomics" Drug Metabolism and Drug Interactions, vol. 28, no. 4, 2013, pp. 191-192. https://doi.org/10.1515/dmdi-2013-0060

van Schaik, R. (2013). New challenges for pharmacogenomics. Drug Metabolism and Drug Interactions, 28(4), 191-192. https://doi.org/10.1515/dmdi-2013-0060

van Schaik, R. (2013) New challenges for pharmacogenomics. Drug Metabolism and Drug Interactions, Vol. 28 (Issue 4), pp. 191-192. https://doi.org/10.1515/dmdi-2013-0060

van Schaik, Ron H.N.. "New challenges for pharmacogenomics" Drug Metabolism and Drug Interactions 28, no. 4 (2013): 191-192. https://doi.org/10.1515/dmdi-2013-0060

van Schaik R. New challenges for pharmacogenomics. Drug Metabolism and Drug Interactions. 2013;28(4): 191-192. https://doi.org/10.1515/dmdi-2013-0060

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 2013-11-23

Published in Print: 2013-12-01

You are currently not able to access this content.

Articles in the same Issue

Masthead
Masthead
Editorial
New challenges for pharmacogenomics
Reviews in Population Pharmacogenomics
Cytochrome P450 genetic polymorphisms of Mexican indigenous populations
Mini Review
Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6
Original Articles
Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping
Influence of Allium sativum extract on the hypoglycemic activity of glibenclamide: an approach to possible herb-drug interaction
A population pharmacokinetic model of remifentanil in pediatric patients using body-weight-dependent allometric exponents
Unexpected interaction between CYP3A4 and BI 11634: is BI 11634 interacting with CYP3A4 similar to nifedipine?
Short Communication
Caffeic acid inhibits organic anion transporters OAT1 and OAT3 in rat kidney

Search journal Search the content of this journal

https://doi.org/10.1515/dmdi-2013-0060

Articles in the same Issue

Masthead
Masthead
Editorial
New challenges for pharmacogenomics
Reviews in Population Pharmacogenomics
Cytochrome P450 genetic polymorphisms of Mexican indigenous populations
Mini Review
Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6
Original Articles
Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping
Influence of Allium sativum extract on the hypoglycemic activity of glibenclamide: an approach to possible herb-drug interaction
A population pharmacokinetic model of remifentanil in pediatric patients using body-weight-dependent allometric exponents
Unexpected interaction between CYP3A4 and BI 11634: is BI 11634 interacting with CYP3A4 similar to nifedipine?
Short Communication
Caffeic acid inhibits organic anion transporters OAT1 and OAT3 in rat kidney